Osaic Holdings’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,500
| Closed | -$900 | – | 7900 |
|
|
2025
Q3 | $900 | Buy |
2,500
+2,320
| +1,289% | +$15.8K | ﹤0.01% | 7390 |
|
|
2025
Q2 | $2.16K | Buy |
180
+113
| +169% | +$1.4K | ﹤0.01% | 6910 |
|
|
2025
Q1 | $920 | Sell |
67
-13
| -16% | -$187 | ﹤0.01% | 6849 |
|
|
2024
Q4 | $1.14K | Hold |
80
| – | – | ﹤0.01% | 6796 |
|
|
2024
Q3 | $1.52K | Hold |
80
| – | – | ﹤0.01% | 6713 |
|
|
2024
Q2 | $1.56K | Sell |
80
-40
| -33% | -$773 | ﹤0.01% | 6691 |
|
|
2024
Q1 | $2.75K | Buy |
120
+53
| +79% | +$1.14K | ﹤0.01% | 6345 |
|
|
2023
Q4 | $1.17K | Sell |
67
-66
| -50% | -$941 | ﹤0.01% | 6702 |
|
|
2023
Q3 | $1.74K | Buy |
133
+40
| +43% | +$606 | ﹤0.01% | 6675 |
|
|
2023
Q2 | $1.57K | Sell |
93
-437
| -82% | -$7.52K | ﹤0.01% | 6746 |
|
|
2023
Q1 | $8.27K | Sell |
530
-133
| -20% | -$2.58K | ﹤0.01% | 6083 |
|
|
2022
Q4 | $11K | Hold |
663
| – | – | ﹤0.01% | 5887 |
|
|
2022
Q3 | $11K | Sell |
663
-160
| -19% | -$3.5K | ﹤0.01% | 5954 |
|
|
2022
Q2 | $18K | Hold |
823
| – | – | ﹤0.01% | 5673 |
|
|
2022
Q1 | $28K | Hold |
823
| – | – | ﹤0.01% | 5468 |
|
|
2021
Q4 | $34K | Buy |
823
+200
| +32% | +$13K | ﹤0.01% | 5427 |
|
|
2021
Q3 | $56K | Buy |
623
+130
| +26% | +$11.5K | ﹤0.01% | 5011 |
|
|
2021
Q2 | $36K | Buy |
493
+333
| +208% | +$15.5K | ﹤0.01% | 5271 |
|
|
2021
Q1 | $6K | Hold |
160
| – | – | ﹤0.01% | 6068 |
|
|
2020
Q4 | $7K | Hold |
160
| – | – | ﹤0.01% | 5646 |
|
|
2020
Q3 | $4K | Hold |
160
| – | – | ﹤0.01% | 5625 |
|
|
2020
Q2 | $5K | Sell |
160
-17
| -10% | -$501 | ﹤0.01% | 5454 |
|
|
2020
Q1 | $4K | Buy |
+177
| New | +$6.54K | ﹤0.01% | 5423 |
|
Other funds holding CLSD
Osaic Holdings's CLSD Position: Q4 2025 in Review
Osaic Holdings sold out of Clearside Biomedical (CLSD) in Q4 2025, closing a stake of 2,500 shares — an estimated $900 sold.
Osaic Holdings first reported a position in CLSD in Q1 2020 and held it in 23 quarters. The position peaked at $56K in Q3 2021. 1 fund tracked by Wall St. Rank holds CLSD as of Q4 2025.
- Osaic Holdings reported no remaining Clearside Biomedical position as of Q4 2025 after selling out during the quarter.
- Osaic Holdings sold 2,500 Clearside Biomedical shares in Q4 2025, an estimated $900.
- Osaic Holdings first reported a position in Clearside Biomedical in Q1 2020 and held it in 23 quarters.
- Osaic Holdings's Clearside Biomedical position peaked at $56K in Q3 2021.
- 1 fund tracked by Wall St. Rank held Clearside Biomedical as of Q4 2025.
Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.